NICE works with the Department of Health's payment by results team to identify the best way to ensure the cost of implementing NICE guidance is reflected in the tariff. In the past, where variation in uptake of high cost drugs may occur it has been the PBR team's policy to exclude the drug cost and leave it to providers and commissioners to agree funding mechanisms locally.